Point Of Care Molecular (POC) Diagnostics Market Growth Rate Analysis 2020 to 2026
The Point Of Care Molecular (POC) Diagnostics Market is poised for robust growth on the back of the burgeoning prevalence of infectious diseases across the globe. In recent years, the global reach of infectious diseases such as flu, tuberculosis, HIV, hepatitis C, and respiratory syncytial virus is expanding at a rapid pace. As per the CDC (Centers for Disease Control and Prevention) estimates, Influenza, a seasonal respiratory virus, was responsible for around 14 million to 21 million medical visits in the United States of America alone since October 1, 2019. Although influenza has an approved antiviral treatment, it is important for patients to get antiviral medicines within 48 hours of symptom onset. This has led to an increase in the demand for early molecular disease diagnosis and quick result interpretation, creating lucrative growth opportunities for the Point of care molecular (POC) diagnostics market Request for a sample of this research report @ https://www.gminsights.c